Extracellular signal-regulated kinase 5 and cyclic AMP response element binding protein are novel pathways inhibited by vandetanib (ZD6474) and doxorubicin in mesotheliomas.
暂无分享,去创建一个
M. Sayan | B. Mossman | A. Shukla | Joyce K Thompson | Jill M. Miller | J. Hillegass | M. MacPherson | S. Beuschel | T. Perkins | S. Macura